Back to Search Start Over

Adaptive Biotechnologies price target lowered by $3 at JPMorgan, here's why

Source :
The Fly. May 8, 2024
Publication Year :
2024

Abstract

JPMorgan lowered the firm's price target on Adaptive Biotechnologies to $5 from $8 and keeps an Overweight rating on the shares. The analyst updated the company's model post the Q1 [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
The Fly
Publication Type :
Periodical
Accession number :
edsgcl.793090372